@article {1549008,
	title = {Optic nerve sheath meningioma},
	journal = {Curr Opin Ophthalmol},
	volume = {31},
	number = {6},
	year = {2020},
	month = {2020 Nov},
	pages = {455-461},
	abstract = {PURPOSE OF REVIEW: Optic nerve sheath meningiomas (ONSMs) are rare benign tumors of the anterior visual pathway which present with slowly progressive and painless vision loss and account for approximately 2\% of all orbital tumors. This article provides an overview as well as an update on the ONSMs with regards to cause, epidemiology, clinical presentation, diagnosis, and management in adults and pediatric population. RECENT FINDINGS: The clinical presentation and prognosis of ONSMs can vary and largely depend on the location of tumor as well as the histologic type. Overall, the diagnosis is based on clinical presentation, examination, and neuroimaging findings. Nevertheless, delays in diagnosis or misdiagnosis are not uncommon and can result in higher morbidity rates. Recent advances in diagnostic as well as more effective and less-invasive treatment options are discussed in this review. SUMMARY: ONSMs are a rare cause of slowly progressive and inexorable visual loss. Although ONSM diagnosis depends on the characteristic clinical and radiologic findings, prompt diagnosis, and appropriate management is critical for favorable visual outcomes. Thus, current focus is optimizing diagnostic as well-treatment methods for patients with ONSMs.},
	keywords = {Humans, Meningioma, Neuroimaging, Optic Nerve Neoplasms, Prognosis, Vision Disorders},
	issn = {1531-7021},
	doi = {10.1097/ICU.0000000000000700},
	author = {Douglas, Vivian Paraskevi and Douglas, Konstantinos Aa and Cestari, Dean M}
}
